$Novavax(NVAX)$Novavax's Matrix M in Malaria Vaccine Shows Promising ResultsR21* is a protein-based investigational vaccine developed by the University of Oxford, using our Matrix-M™ adjuvant technology.1 This investigational vaccine is specifically designed to help protect against malaria.https://www.economist.com/science-and-technology/2022/09/08/a-new-malaria-vaccine-shows-promising-results